Rising Incidence Of Bone-Related Diseases To Drive Growth In The Bone and Mineral Diagnostic Testing Market: Critical Driver Shaping the Bone and Mineral Diagnostic Testing Market in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Bone and Mineral Diagnostic Testing Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In the past years, there has been a consistent growth in the size of the bone and mineral diagnostic testing market. It is projected that the market worth will increase from $1.09 billion in 2024 to $1.14 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 4.9%. Factors such as the demands of an aging population, the prevalence of osteoporosis, expanded awareness and education initiatives, the clinical requirement for monitoring, and the assessment of fracture risk have contributed to growth throughout the historical period.

Bone and Mineral Diagnostic Testing Market Size Forecast: What's the Projected Valuation by 2029?
Expect robust expansion in the bone and mineral diagnostic testing market in the coming years, with the forecast predicting the market size to reach "$1.42 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 5.6%. The predicted growth during this period can be ascribed to progressing diagnostic technologies, rising incidences of metabolic bone diseases, heightened emphasis on preventive healthcare, and incorporation of personalized medicine methodologies. Key trends projected for this period encompass the incorporation of biochemical markers, telemedicine and remote patient monitoring, the proliferation of home-based testing kits, partnerships for research and innovation, and a focus on all-inclusive diagnostic panels.

View the full report here:
https://www.thebusinessresearchcompany.com/report/bone-and-mineral-diagnostic-testing-global-market-report

What Are the Drivers Transforming the Bone and Mineral Diagnostic Testing Market?
The anticipated rise in bone-related illnesses is predicted to boost the bone and mineral diagnostic testing market's growth. These diseases, which impair bone strength or flexibility, lead to frailty, an increased likelihood of fractures, and symptoms including bone pain, movement difficulties, and a heightened fracture risk. Bone density tests and other bone and mineral diagnostic tests help curb these maladies by spotting low bone density ahead of osteoporosis development, predicting future fracture risks, and monitoring the effectiveness of current osteoporosis therapies. The mounting prevalence of bone-related diseases, combined with the growth in awareness and technological advancements, is projected to drive the bone and mineral diagnostic testing market. For instance, The National Center for Biotechnology Information (NCBI), a government organization in the US, determined in May 2022 that osteoporosis' main complication is fracture, speculating a 310% rise in global hip fractures in men and a 240% rise in women by 2050. Consequently, a surge in bone-related disease occurrences will fuel the bone and mineral diagnostic testing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10731&type=smp

What Long-Term Trends Will Define the Future of the Bone and Mineral Diagnostic Testing Market?
Developments in technology are a vital focal point of growth in the bone and mineral diagnostic testing industry. In order to retain their market positions, companies within this sector are resorting to new technological transformations. For instance, in May 2022, GE HealthCare Technologies Inc, a US-based firm concentrated on medical technology, harnessed an innovative MRI technique boasting unique pulse sequences like zero echo time (ZTE). This inventive progression in MR bone imaging allows for CT-like image contrast in 3D isotropic resolution while eliminating the patient's exposure to ionizing radiation. It's mainly used to procure structural information concerning cortical bone within anatomical structures, including the shoulder, hip, skull, foot/ankle, and spine. This new potential is particularly enticing when continuous CTs are needed, especially if less-dose CTs are not accessible.

Which Segments in the Bone and Mineral Diagnostic Testing Market Offer the Most Profit Potential?
The bone and mineral diagnostic testing market covered in this report is segmented -

1) By Product: Assays Or Consumables, Instruments
2) By Test Type: Enzyme-Linked Immunosorbent Assay (ELISA), Clinical Laboratory Improvement Amendments (CLIA), Other Test Types
3) By Application: Vitamin D Testing, Bone Metabolism

Subsegments:
1) By Assays Or Consumables: Bone Turnover Markers Assays, Vitamin D Assays, Calcium And Phosphate Assays, Sample Collection Kits, Reagents And Standards
2) By Instruments: Bone Densitometers, X-Ray Machines, Ultrasound Devices, MRI Machines, Other Diagnostic Instruments

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10731&type=smp

Which Firms Dominate the Bone and Mineral Diagnostic Testing Market by Market Share and Revenue in 2025?
Major companies operating in the bone and mineral diagnostic testing market include Abbott Laboratories, bioMérieux SA, DiaSorin S.p.A., QuidelOrtho Corporation, Siemens Healthineers AG, F. Hoffmann-La Roche AG, GE HealthCare Technologies Inc., Hologic Inc., Beammed Ltd., Swissray International Inc., Osteosys Co. Ltd., Diagnostic Medical System SA, Medonica Co. Ltd., Epitope Diagnostics Inc., Alere Inc., Beckman Coulter Inc., Bio Rad Laboratories Inc., Calbiotech Inc., Roche Diagnostics India Pvt. Ltd., Ortho-Clinical Diagnostics, Enzo Life Sciences lnc., Medtronic plc, Thermo Fisher Scientific lnc., Sysmex Corporation, EKF Diagnostics, Bruker Corporation, Esaote SpA, Hitachi Ltd., Koninklijke Philips N.V., Mindray Medical International Limited, PerkinElmer Inc., Shimadzu Corporation, Toshiba Medical Systems Corporation, Waters Corporation, Danaher Corporation, Merck KGaA

Which Regions Offer the Highest Growth Potential in the Bone and Mineral Diagnostic Testing Market?
North America was the largest region in the bone and mineral diagnostic testing market in 2024. The regions covered in the bone and mineral diagnostic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10731

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.